Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Field Trip Health Ltd. (FTRP) has applied to list its common shares on the NASDAQ Stock Market
  • In advance of an anticipated listing on NASDAQ, Field Trip will file a Registration Statement with the SEC
  • Field Trip will continue to maintain the listing of its Shares on the Toronto Stock Exchange under the symbol FTRP
  • Field Trip is a global leader in the development and delivery of psychedelic therapies
  • Field Trip Health Ltd. (FTRP) is up 3.55 per cent, trading at C$5.55 per share at 10:15 am ET

Field Trip Health Ltd. (FTRP) has applied to list its common shares on the NASDAQ Stock Market.

“Psychedelics stand poised to disrupt modern psychiatry, and the NASDAQ is where world class companies whose ambition is disruption list to reach a global audience of investors,” said Ronan Levy, Field Trip’s Executive Chairman.

“By applying to list on the NASDAQ, we are declaring to the world that Field Trip is such a world class company.”

Hannan Fleiman, co-Founder and President, said,

“With our drug development program advancing work on FT-104, our next generation psychedelic molecule, and our renowned Field Trip Health Centers opening up across North America, Field Trip is positioned to be the global leader in the psychedelics industry. Following our successful listing on the TSX in Canada, we are now taking the first steps to list on the NASDAQ, a move which would greatly increase the ability of US investors to participate in this growth.”

By the end of 2021, Field Trip anticipates being able to commence Phase 1 human trials for FT-104 and expects to have 20 Field Trip Health centers operating or under construction, including its existing and announced locations in New York, NY, Toronto, ON, Los Angeles, CA, Chicago, IL, Houston, TX, Atlanta, GA, San Diego, CA, San Jose, CA, Seattle, WA, Washington, DC, Fredericton, NB and Amsterdam, NL.

In advance of an anticipated listing on NASDAQ, Field Trip will file a Registration Statement with the United States Securities and Exchange Commission. The listing of Common Shares on NASDAQ remains subject to the review and approval of the listing application and the satisfaction of all applicable listing and regulatory requirements.

Field Trip will continue to maintain the listing of its Shares on the Toronto Stock Exchange under the symbol FTRP.

There will be no change to the shares, warrants or to Field Trip’s share structure. Field Trip’s shares continue to be quoted in the United States on the OTCQX under the symbol “FTRPF” until such a time that they are listed on the NASDAQ.

Field Trip is a global leader in the development and delivery of psychedelic therapies. 

Field Trip Health Ltd. (FTRP) is up 3.55 per cent, trading at C$5.55 per share at 10:15 am ET.

More From The Market Herald

" Optimi Health (CSE:OPTI) acquires catalog of psychedelic and functional mushroom genetics

Optimi Health (OPTI) has acquired a catalog of psilocybin and functional mushroom strains.

" Nirvana Life Sciences Inc (CSE:NIRV) signs LOI with Innovate Phytotechnologies Inc

Nirvana Life Sciences (NIRV) has  signed a letter of intent with Innovate Phytotechnologies Inc. (INVP)
Clearmind Medicine - CEO, Adi Zuloff Shani.

" Clearmind Medicine (CSE:CMND) announces upcoming pre-IND meeting with the FDA

Clearmind (CMND) will participate in a pre-IND meeting with the FDA on May 18, 2022.
Red Light Holland - Advisor, Akwasi Owusu Bempah.

" Red Light Holland (CSE:TRIP) adds Akwasi Owusu-Bempah to Advisory Board

Red Light Holland (TRIP) has hired drug law expert Akwasi Owusu-Bempah as its newest advisor.